The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Lively, Practical Training at Advocacy 101

Lively, Practical Training at Advocacy 101

October 11, 2021 • By Leslie Mertz, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR fellows, committee members and others learned ways to promote positive changes on issues that affect their practices and their patients during the ACR’s Advocacy 101 program, held in association with the annual Capitol Hill virtual Advocates for Arthritis “fly-in” in late September.

You Might Also Like
  • Advocacy 101 Teaches Legislative, Advocacy Basics
  • Learn to Share Your Voice at Advocacy 101
  • ACR Offers Hands-On 101 Course in Advocacy
Also By This Author
  • Study: Don’t Automatically Blame Burnout on Electronic Health Records
Dr. Amanda Schnell

Dr. Schnell

The virtual program included a mix of general sessions and breakouts covering topics from federal- and state-level legislative advocacy to concerns about insurance, high drug costs and patient accessibility to services. “Everyone was really excited to talk about these issues,” says Advocacy 101 organizer Amanda Schnell, MD, assistant professor in the Division of Clinical Immunology and Rheumatology and program director of the Rheumatology Fellowship Program at the University of Alabama at Birmingham. She is also a member of the ACR’s Government Affairs Committee.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Putting Information into Practice

These kinds of discussions are particularly crucial for new rheumatologists, Dr. Schnell says. With insurance, for example, the attending physician typically handles the back-office processes required to obtain insurance approvals for the often-expensive drugs rheumatologists prescribe. “Providing education about this aspect when rheumatologists are in training—whether that be in medical school, residency or even fellowship—is important so they understand how it works, how it is going to affect their practice after they graduate fellowship and how they can effect changes that will improve access to care for all of our patients,” she asserts.

During the program, participants also got hands-on experience advocating for two pieces of legislation. One was H.R.3173, the Improving Seniors’ Timely Access to Care Act of 2021, which is designed to speed patient access to care by allowing the Centers for Medicare & Medicaid Services (CMS) to regulate the usage of prior authorization in Medicare Advantage plans. The bill would also establish a process for real-time decision making and finally switch from paper to electronic prior authorization forms, Dr. Schnell says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The second bill, the Pharmacy Benefit Manager Accountability Study Act (S.298/H.R.1829), is currently in both the Senate and the House and would require the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain. That role is not as transparent as it should be, Dr. Schnell notes. “Drug pricing is very complex and includes the drug manufacturer, insurance companies, pharmacy benefit managers and the pharmaceutical industry. The requirements of this bill should give us more information about where high drug costs are coming from,” she says.

Building on Connections

Deepika Singh, MD

Dr. Singh

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy Tagged With: Advocacy 101, Advocates for Arthritis, Amanda Schnell, Deepika Singh, Legislation & Advocacy, Samuel Gagne

You Might Also Like:
  • Advocacy 101 Teaches Legislative, Advocacy Basics
  • Learn to Share Your Voice at Advocacy 101
  • ACR Offers Hands-On 101 Course in Advocacy
  • ACR’s 2018 Advocates for Arthritis & Advocacy 101 Program

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)